To explain to Bayswater Primary School parents, carers, staff and students the processes and procedures in place to support students diagnosed as being at risk of suffering from anaphylaxis. This policy also ensures that Bayswater Primary School is compliant with Ministerial Order 706 and the Department’s guidelines for anaphylaxis management.
This policy applies to:
Bayswater Primary School will fully comply with Ministerial Order 706 and the associated guidelines published by the Department of Education.
Anaphylaxis is a severe allergic reaction that occurs after exposure to an allergen. The most common allergens for school-aged children are nuts, eggs, cow’s milk, fish, shellfish, wheat, soy, sesame, latex, certain insect stings and medication.
Signs and symptoms of a mild to moderate allergic reaction can include:
Signs and symptoms of anaphylaxis, a severe allergic reaction, can include:
Symptoms usually develop within ten minutes and up to two hours after exposure to an allergen, but can appear within a few minutes.
Adrenaline given as an injection into the muscle of the outer mid-thigh is the first aid treatment for anaphylaxis.
Individuals diagnosed as being at risk of anaphylaxis are prescribed an adrenaline autoinjector for use in an emergency. These adrenaline autoinjectors are designed so that anyone can use them in an emergency.
All students at Bayswater Primary School who are diagnosed by a medical practitioner as being at risk of suffering from an anaphylactic reaction must have an Individual Anaphylaxis Management Plan. When notified of an anaphylaxis diagnosis, the Principal of Bayswater Primary School is responsible for developing a plan in consultation with the student’s parents/carers.
Where necessary, an Individual Anaphylaxis Management Plan will be in place as soon as practicable after a student enrols at Bayswater Primary School and where possible, before the student’s first day.
Parents and carers must:
Each student’s Individual Anaphylaxis Management Plan must include:
A student’s Individual Anaphylaxis Management Plan will be reviewed and updated on an annual basis in consultation with the student’s parents/carers. The plan will also be reviewed and, where necessary, updated in the following circumstances:
Our school may also consider updating a student’s Individual Anaphylaxis Management Plan if there is an identified and significant increase in the student’s potential risk of exposure to allergens at school.
A copy of each student’s Individual Anaphylaxis Management Plan will be stored with their ASCIA Action Plan for Anaphylaxis at their classroom and the first aid room. Whilst some students keep their adrenaline autoinjector on their person, medication for those that do not will be stored and labelled with their name at the first aid room, together with adrenaline autoinjectors for general use.
To reduce the risk of a student suffering from an anaphylactic reaction at Bayswater Primary School, we have put in place the following strategies:
Planning for off-site activities will include risk minimisation strategies for students at risk of anaphylaxis including supervision requirements, appropriate number of trained staff, emergency response procedures and other risk controls appropriate to the activity and students attending.
Bayswater Primary School will maintain a supply of adrenaline autoinjector(s) for general use, as a back-up to those provided by parents and carers for specific students, and also for students who may suffer from a first-time reaction at school.
There are currently 4 adrenaline devices approved by the Therapeutic Goods Administration for use in Australia: the EpiPen®, the Anapen®, Jext® and Neffy®. All devices can be used when provided by families for students, however, the principal or allocated staff member can only use Epipen®, Anapen® or Jext® adrenaline autoinjector for general use. For more information about which autoinjector to purchase for general use, refer to Adrenaline autoinjectors for general use.
Adrenaline autoinjectors for general use will be stored at the first aid room and labelled “general use”.
The principal is responsible for arranging the purchase of adrenaline autoinjectors for general use, and will consider:
In the event of an anaphylactic reaction, the emergency response procedures in this policy must be followed, together with the school’s general first aid procedures, emergency response procedures and the student’s Individual Anaphylaxis Management Plan.
A complete and up-to-date list of students identified as being at risk of anaphylaxis is maintained by the Business Manager and stored in the first aid room. For camps, excursions and special events, a designated staff member will be responsible for maintaining a list of students at risk of anaphylaxis attending the special event, together with their Individual Anaphylaxis Management Plans and adrenaline autoinjectors, where appropriate.
If a student experiences an anaphylactic reaction at school or during a school activity, school staff must:
Step
Action
1
· Lay the person flat
· Do not allow them to stand or walk
· If breathing is difficult, allow them to sit
· Be calm and reassuring
· Do not leave them alone
· Seek assistance from another staff member or reliable student to locate the student’s adrenaline autoinjector or the school’s general use autoinjector, and the student’s Individual Anaphylaxis Management Plan, stored in the first aid room
· If the student’s plan is not immediately available, or they appear to be experiencing a first time reaction, follow steps 2 to 5
2
Administer an Adrenaline autoinjector or Adrenaline autoinjector Jr
· Remove from plastic container
· Form a fist around the Adrenaline autoinjector and pull off the blue safety release (cap)
· Place orange end against the student’s outer mid-thigh (with or without clothing)
· Push down hard until a click is heard or felt and hold in place for 3 seconds
· Remove Adrenaline autoinjector
· Note the time the Adrenaline autoinjector is administered
· Retain the used Adrenaline autoinjector to be handed to ambulance paramedics along with the time of administration
OR
Administer an Anapen® 500, Anapen® 300, or Anapen® Jr.
· Pull off the black needle shield
· Pull off grey safety cap (from the red button)
· Place needle end firmly against the student's outer mid-thigh at 90 degrees (with or without clothing)
· Press red button so it clicks and hold for 3 seconds
· Remove Anapen®
· Note the time the Anapen is administered
· Retain the used Anapen to be handed to ambulance paramedics along with the time of administration
Administer Jext 150 or 300
· Form fist around Jext and pull off yellow cap
· Place black injector tip against outer-mid thigh (with or without clothing)
· Push black tip firmly until a click is heard and hold in place for 3 seconds.
· Remove Jext
· Note the time the Jext device is administered.
· The used adrenaline device must be handed to the ambulance paramedics along with the time of administration
Administer Neffy® 1mg or 2mg
· Hold the nasal spray with your thumb on the bottom of the plunger and a finger on either side of the nozzle.
· Do not pull or push on the plunger. Do not test or prime (pre-spray). Each Neffy nasal spray contains only one spray.
· Place the nozzle of the nasal spray into a nostril until fingers touch the nose.
· For smaller nostrils, aim for the fingers to touch the nose.
· Keep the nozzle pointed towards the forehead. Do not angle the nozzle of the nasal spray to the inner or outer walls of the nose.
· Press the plunger up firmly until the dose is administered and it sprays into the nostril.
· Note the time the Neffy device is administered.
3
Call an ambulance (000)
4
If there is no improvement or severe symptoms progress (as described in the ASCIA Action Plan for Anaphylaxis), further adrenaline doses may be administered every five minutes, if other adrenaline autoinjectors are available.
5
Contact the student’s emergency contacts.
6
The principal or a staff member allocated to do so must contact the Incident Support and Operations Centre (ISOC) on 1800 126 126 to report ‘High’ or Extreme’ severity incidents to report the incident. Incidents assessed as ‘Low’ or ‘Medium’ can be reported directly into EduSafe Plus by the principal or their allocated staff member.
If a student appears to be having a severe allergic reaction, but has not been previously diagnosed with an allergy or being at risk of anaphylaxis, school staff should follow steps 2 to 5 as above.
For first time anaphylactic reactions, the school’s general use adrenaline autoinjector device must be used. If the general use device is not immediately available in an anaphylaxis emergency, staff may use another student's adrenaline device, including the Epipen®, Anapen®, Jext® or Neffy® device. This may save a life. If another student's adrenaline device is used in an anaphylaxis emergency, the school must notify the parents of the student whose device was used and immediately replace the device.
Where possible, schools should consider using the correct dose of adrenaline autoinjector depending on the weight of the student. However, in an emergency if there is no other option available, any device should be administered to the student.
This policy will be available on Bayswater Primary School’s website so that parents and other members of the school community can easily access information about Bayswater Primary School’s anaphylaxis management procedures.
The principal is responsible for ensuring that all relevant staff, including casual relief staff, canteen staff and volunteers are aware of this policy and Bayswater Primary School’s procedures for anaphylaxis management. We will communicate this policy through staff induction and training materials, and twice-yearly staff briefings. Casual relief staff and volunteers who are responsible for the care and/or supervision of students who are identified as being at risk of anaphylaxis will also receive a verbal briefing on this policy, their role in responding to an anaphylactic reaction and where required, the identity of students at risk.
We will also communicate this policy through:
The principal is also responsible for ensuring relevant staff are trained and briefed in anaphylaxis management, consistent with the Department’s Anaphylaxis Guidelines.
The Principal will ensure that the following school staff are appropriately trained in anaphylaxis management:
Staff who are required to undertake training must have completed:
Bayswater Primary School uses the following training course: Online training — ASCIA Anaphylaxis e-training for Victorian Schools with Anaphylaxis Supervisors completing Course in Verifying the Correct Use of Adrenaline Injector Devices 22579VIC.
Staff are also required to attend a briefing on anaphylaxis management and this policy at least twice per year (with the first briefing to be held at the beginning of the school year), facilitated by a staff member who has successfully completed an anaphylaxis management course within the last 2 years including the School Anaphylaxis Supervisor. Each briefing will address:
When a new student enrols at Bayswater Primary School who is at risk of anaphylaxis, the Principal will develop an interim plan in consultation with the student’s parents and ensure that appropriate staff are trained and briefed as soon as possible.
A record of staff training courses and briefings will be maintained through the school’s online Emergency Management Plan.
The Principal will ensure that while students at risk of anaphylaxis are under the care or supervision of the school outside of normal class activities, including in the school yard, at camps and excursions, or at special event days, there is a sufficient number of school staff present who have been trained in anaphylaxis management.
This policy should be read in conjunction with the Anaphylaxis policy on the Department’s Policy and Advisory Library (PAL) and the following resources:
Policy last reviewed
August 2026
Approved by
Principal
Next scheduled review date
Before August 2027
The principal will complete the Department’s Annual Risk Management Checklist for anaphylaxis management to assist with the evaluation and review of this policy and the support provided to students at risk of anaphylaxis.